Clinical Trial Update: Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating radiation combined with immune checkpoint blockade in metastatic non-small cell lung cancer was terminated; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Non Small Cell Lung Cancer Metastatic | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-04-24